Market Place
Sourcing Support
Second Chinese drugmaker seeks approval for Ozempic generic
13 Jun 2024 //
REUTERS
Livzon Pharma`s COVID vaccine gets approval as booster in China
03 Sep 2022 //
REUTERS
Livzon Pharmaceutical Group was recognized as the National Enterprise
20 Apr 2022 //
PRESS RELEASE
A Recombinant SARS-Cov-2 Fusion Protein Vaccine (V-01) developed & manufactured
20 Apr 2022 //
PRESS RELEASE
Livzon Rapid Test for 2019-nCoV-2 Antigen (Lateral Flow) approved by China NMPA.
20 Apr 2022 //
PRESS RELEASE
Livzon Antiviral Granules are recommended for mild & common infections COVID-19
20 Apr 2022 //
PRESS RELEASE
Livzon`s COVID-19 vaccine appears safe, triggers antibodies -study
09 Jul 2021 //
REUTERS
China approves clinical trials for Livzon Pharma unit`s COVID-19 vaccine
23 Mar 2021 //
REUTERS
Livzon participated in the 39th Annual JP Morgan Medical Health Conference
15 Jan 2021 //
PRESS RELEASE
LTS and LIVZON enter into license and collaboration agreement to develop
06 Jul 2020 //
LTSLOHMANN
Livzon Won the 19th China Patent Award of Excellence
20 Jun 2018 //
PRESS RELEASE
Ilaprazole Sodium for Injection was Approved for Production
10 Jan 2018 //
PRESS RELEASE
Clinical investigation For the Project “Recombinant Anti-PD-1 Monoclonal
01 Aug 2017 //
PRESS RELEASE
Livzon Group Fuzhou Fuxing becomes the first local Mfg to be awarded EU GMP
03 Apr 2013 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.